Computer Models Demo Bird Flu Migration



Computer simulation public health experts preparing for a feared avian flu pandemic are using computer models to get a glimpse of how the disease might spread if the bird virus were to start passing between people.

Based on their first models -- of an outbreak in Southeast Asia -- researchers affiliated with the Models of Infectious Disease Agent Study (Midas) research network have concluded that immediate treatment with vaccines and antiviral drugs, in combination with quarantines and other public health measures, could contain a pandemic.

"In the past, there hasn’t been much effort to work out predictions of how a disease might spread," says Irene Eckstrand, scientific director at Midas. "These models have shown that if you’re going to contain the flu, you’ve got to do it really fast."

Midas is funded by the National Institute of General Medical Sciences. Midas researchers in the United States and Britain are working along with other U.S. government agencies and the World Health Organization to outline how best to control a nascent flu epidemic.

The flu models are based in part on models developed in England in the 1990s to deal with an outbreak of foot-and-mouth disease among livestock. To model the avian flu, researchers used a cluster of 32 processors to simulate how 500,000 individuals in Thailand move and interact during a given period of time. The models simulate where each person is likely to go each day and how many people he or she will come in contact with. The model showed that a virus would spread "like ink blots all over the place," Eckstrand says. The data revealed that an outbreak could take off quickly and would be difficult to contain unless health-care professionals and public health officials took action immediately.

Now the researchers are using supercomputers to create a similar model for the much larger U.S. population, says Ira Longini, a professor of biostatistics at Emory University and the leader of the Emory research group affiliated with the Midas project. The U.S. model requires supercomputers because it will simulate the movements of many more individuals than the original model, Longini says.

Public health experts agree that there will be another global flu epidemic, although they are not sure when or how severe it will be. They are also not sure whether the bird flu strain -- known as H5N1 -- will be the origin of such a pandemic, although experts fear that the virus could mutate and start spreading among humans.

In the past, the spread of infectious disease was usually limited because people lived in smaller towns, and they didn’t travel much. "Now, with planes flying between major capitals, everyone is connected to everyone else," Eckstrand says. "That’s why it’s potentially so important to create computer models that show how people are connected."

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .